Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Press Statements

      AbCellera’s Rapid Pandemic Response Platform Contributes to the World’s First COVID-19 Clinical Trial for a Potential Monoclonal Antibody Treatment

      Clinical Trials
      AbCellera announced that LY-CoV555, the lead antibody from the collaboration between AbCellera and Eli Lilly and Company (Lilly), has entered into human testing for...

      Klockner Pentaplast Expands in North America to Support the Pharmaceutical Market

      Press Statements
      Klöckner Pentaplast, a manufacturer of pharmaceutical barrier packaging films, broke ground on a large expansion at its Klöckner Barrier Film (KBF) facility in central...

      Honeywell Expedites Development and Production of Vital Vaccines and Medical Therapies with Fast Track Automation

      Manufacturing
      Honeywell announced Fast Track Automation, a combination of proprietary technology innovations for the life sciences industry that enables vital vaccines, treatments and therapies to...

      AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ for the Treatment of Adults with Active Psoriatic Arthritis

      FDA Approvals
      AbbVie , a research-based global biopharmaceutical company, announced that it has submitted applications for a new indication to the U.S. FDA and European Medicines...

      Daiichi Sankyo and Syneos Health Form Strategic Coalition for Development of Daiichi Sankyo’s ADC Oncology Pipeline

      Drug Development
      Daiichi Sankyo, Inc. announced that it has entered into a strategic agreement with Syneos Health The companies are coming together to form a coalition...

      Regeneron, Intellia to develop CRISPR/Cas9-based treatments

      Clinical Trials
      Regeneron Pharmaceuticals, Inc. and Intellia Therapeutics, Inc. announced an expansion of their existing collaboration to provide Regeneron with rights to develop products for additional...

      Proteostasis Therapeutics Announces In Vitro Data for PTI-129 as Potential Treatment Candidate for COVID-19

      Drug Development
      Proteostasis Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), announced results...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.